PHASE II TRIAL OF A SURVIVIN VACCINE (SurVaxM) FOR NEWLY DIAGNOSED GLIOBLASTOMA

被引：0

作者：

Ahluwalia, Manmeet ^{[1
]}

Reardon, David ^{[2
]}

Abad, Ajay ^{[3
]}

Curry, William ^{[4
]}

Wong, Eric ^{[5
]}

Peereboom, David ^{[1
]}

Belal, Ahmed ^{[3
]}

Qiu, Jingxin ^{[3
]}

Mogensen, Kathleen ^{[3
]}

Schilero, Cathy ^{[1
]}

Casucci, Danielle ^{[3
]}

Mechtler, Laszlo ^{[3
]}

Uhlmann, Erik ^{[3
]}

Ciesielski, Michael ^{[3
]}

Fenstermaker, Robert ^{[3
]}

机构：

[1] Cleveland Clin, Cleveland, OH 44106 USA

[2] Dana Farber Canc Inst, Boston, MA 02115 USA

[3] Roswell Pk Canc Inst, Buffalo, NY 14263 USA

[4] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02115 USA

[5] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

来源：

NEURO-ONCOLOGY | 2018年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ATIM-41

引用

页码：10 / 11

页数：2

共 50 条

[31] PHASE I/IIA TRIAL OF AUTOLOGOUS FORMALIN-FIXED TUMOR VACCINE IN TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME [J].

Muragaki, Yoshihiro ;

Maruyama, Takashi ;

Iseki, Hiroshi ;

Takakura, Kintomo ;

Tanaka, Masahiko ;

Shinohara, Chie ;

Tsuboi, Koji ;

Yamamoto, Tetsuya ;

Matsumura, Akira ;

Matsutani, Masao ;

Karasawa, Katsuyuki ;

Ohno, Tadao ;

Hori, Tomokatsu .

NEURO-ONCOLOGY, 2009, 11 (06) :883-883

[32] A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma [J].

Gilbert, Mark R. ;

Dignam, James J. ;

Armstrong, Terri S. ;

Wefel, Jeffrey S. ;

Blumenthal, Deborah T. ;

Vogelbaum, Michael A. ;

Colman, Howard ;

Chakravarti, Arnab ;

Pugh, Stephanie ;

Won, Minhee ;

Jeraj, Robert ;

Brown, Paul D. ;

Jaeckle, Kurt A. ;

Schiff, David ;

Stieber, Volker W. ;

Brachman, David G. ;

Werner-Wasik, Maria ;

Tremont-Lukats, Ivo W. ;

Sulman, Erik P. ;

Aldape, Kenneth D. ;

Curran, Walter J., Jr. ;

Mehta, Minesh P. .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (08) :699-708

[33] A randomized trial of bevacizumab for newly diagnosed glioblastoma [J].

Schiff, David ;

Huse, Jason ;

Wen, Patrick .

NEURO-ONCOLOGY, 2014, 16 (06) :769-770

[34] A randomized phase II trial of efficacy and safety of the immunotherapy ALECSAT as an adjunct to radiotherapy and temozolomide for newly diagnosed glioblastoma [J].

Werlenius, Katja ;

Stragliotto, Giuseppe ;

Strandeus, Michael ;

Blomstrand, Malin ;

Caren, Helena ;

Jakola, Asgeir S. ;

Rydenhag, Bertil ;

Dyregaard, Dorte ;

Dzhandzhugazyan, Karine N. ;

Kirkin, Alexei F. ;

Raida, Martin K. ;

Smits, Anja ;

Kinhult, Sara .

NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)

[35] Phase II trial of copper depletion as angiosuppressive treatment in newly diagnosed Glioblastoma Multiforme: Final report. [J].

Brem, S ;

Grossman, SA ;

Carson, KA ;

New, P ;

Phuphanich, S ;

Alavi, JB ;

Mikkelsen, T ;

Priet, R .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :114S-114S

[36] Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization [J].

Rahman, Rifaquat ;

Trippa, Lorenzo ;

Lee, Eudocia Q. ;

Arrillaga-Romany, Isabel ;

Fell, Geoffrey ;

Touat, Mehdi ;

McCluskey, Christine ;

Wiley, Jennifer ;

Gaffey, Sarah ;

Drappatz, Jan ;

Welch, Mary R. ;

Galanis, Evanthia ;

Ahluwalia, Manmeet S. ;

Colman, Howard ;

Nabors, L. Burt ;

Hepel, Jaroslaw ;

Elinzano, Heinrich ;

Schiff, David ;

Chukwueke, Ugonma N. ;

Beroukhim, Rameen ;

Nayak, Lakshmi ;

McFaline-Figueroa, J. Ricardo ;

Batchelor, Tracy T. ;

Rinne, Mikael L. ;

Kaley, Thomas J. ;

Lu-Emerson, Christine ;

Mellinghoff, Ingo K. ;

Bi, Wenya Linda ;

Arnaout, Omar ;

Peruzzi, Pier Paolo ;

Haas-Kogan, Daphne ;

Tanguturi, Shyam ;

Cagney, Daniel ;

Aizer, Ayal ;

Doherty, Lisa ;

Lavallee, Maria ;

Fisher-Longden, Brittany ;

Dowling, Shanna ;

Geduldig, Jack ;

Watkinson, Fiona ;

Pisano, William ;

Malinowski, Seth ;

Ramkissoon, Shakti ;

Santagata, Sandro ;

Meredith, David M. ;

Chiocca, E. Antonio ;

Reardon, David A. ;

Alexander, Brian M. ;

Ligon, Keith L. ;

Wen, Patrick Y. .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (36) :5524-+

[37] Phase I/II study of pazopanib and temozolomide in patients with newly diagnosed and resected glioblastoma: Pazoglio trial. [J].

Saada-Bouzid, Esma ;

Frenel, Jean-Sebastien ;

Augereau, Paule ;

Bourg, Veronique ;

Gal, Jocelyn ;

Jacquinot, Rique ;

Gourmelon, Carole ;

Chateau, Yann ;

Barriere, Jerome ;

Bondiau, Pierre-Yves .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)

[38] MRI changes in patients with newly diagnosed glioblastoma treated as part a Phase II trial with bavituximab, radiation, and temozolomide [J].

Ly, Ina ;

Cardona, Jonathan ;

Beers, Andrew ;

Chang, Ken ;

Brown, James ;

Reardon, David ;

Arrillaga-Romany, Isabel ;

Dietrich, Jorg ;

Forst, Deborah ;

Lee, Eudocia ;

Jordan, Justin ;

Nayak, Lakshmi ;

Wen, Patrick ;

Batchelor, Tracy ;

Curry, William ;

Kalpathy-Cramer, Jayashree ;

Gerstner, Elizabeth .

NEUROLOGY, 2019, 92 (15)

[39] PriCoTTF: A PHASE I/II TRIAL OF TUMOR TREATING FIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA [J].

Glas, Martin ;

Scheffler, Bjoern ;

Lazaridis, Lazaros ;

Herrlinger, Ulrich ;

Pierscianek, Daniela ;

Sure, Ulrich ;

Proescholdt, Martin ;

Hau, Peter ;

Hense, Joerg ;

Kleinschnitz, Christoph ;

Grosu, Anca-Ligia ;

Stuschke, Martin ;

Kebir, Sied .

NEURO-ONCOLOGY, 2018, 20 :22-22

[40] MRI CHANGES IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED AS PART OF A PHASE II TRIAL WITH BAVITUXIMAB, RADIATION, AND TEMOZOLOMIDE [J].

Ly, Ina ;

Cardona, Jonathan ;

Beers, Andrew ;

Chang, Ken ;

Brown, James ;

Reardon, David ;

Arrillaga-Romany, Isabel ;

Dietrich, Jorg ;

Forst, Deborah ;

Lee, Eudocia ;

Jordan, Justin ;

Nayak, Lakshmi ;

Wen, Patrick ;

Batchelor, Tracy ;

Kalpathy-Cramer, Jayashree ;

Gerstner, Elizabeth .

NEURO-ONCOLOGY, 2018, 20 :191-191

← 1 2 3 4 5 →